Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study

CONCLUSION: Pregabalin increases the quality of life in patients with subacute and chronic cough resistant to standard treatment and increases the rate of recovery in these patients.PMID:37888808 | DOI:10.2174/0115748871262516230919070559

Source: Reviews on Recent Clinical Trials - October 27, 2023 Category: Cancer & Oncology Authors: Seyed Hasan Adeli Abolfazl Mohammad Beigi Sajjad Ahmadpour Mohammad Amin Habibi Mohammad Reza Pashaei Ehsan Sharifipour Mansoureh Shakeri Akram Asghari Source Type: research